Calidi Biotherapeutics Inc Share Price Today: Live Updates & Key Insights

Calidi Biotherapeutics Inc share price today is $0.283, up -5.57%. The stock opened at $0.2953 against the previous close of $0.2997, with an intraday high of $0.2953 and low of $0.2803.

Calidi Biotherapeutics Inc Share Price Chart

Calidi Biotherapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Calidi Biotherapeutics Inc Share Price Performance

$0.283 -0.0557(-5.57%) CLDI at 23 Mar 2026 12:28 PM Biotechnology
Lowest Today 0.2803
Highest Today 0.2953
Today’s Open 0.2953
Prev. Close 0.2997
52 Week High 13.20
52 Week Low 0.28
Day’s Range: Low 0.2803 High 0.2953
52-Week Range: Low 0.28 High 13.20
1 day return -
1 Week return -12.62
1 month return -62.69
3 month return -79.83
6 month return -82.13
1 year return -60.79
3 year return -97.23
5 year return -97.12
10 year return -

Calidi Biotherapeutics Inc Institutional Holdings

Calidi Biotherapeutics Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Calidi Biotherapeutics Inc Fundamentals

Market Cap 2.69 M

PB Ratio 0.4114

PE Ratio 0.7861

Enterprise Value -4.38 M

Total Assets 14.18 M

Volume 320207

Calidi Biotherapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY21:449000 0.4M, FY20:0 0.0M

Annual Profit FY23:0 0.0M, FY21:355000 0.4M, FY20:0 0.0M

Annual Net worth FY23:-29216000 -29.2M, FY21:-10933000 -10.9M, FY20:-7937000 -7.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-427000 -0.4M, Q2/2025:-407000 -0.4M, Q1/2025:-394000 -0.4M, Q3/2024:null 0.0M, Q2/2024:-378000 -0.4M

Quarterly Net worth Q3/2025:-5149000 -5.1M, Q2/2025:-5715000 -5.7M, Q1/2025:-4986000 -5.0M, Q3/2024:-5054000 -5.1M, Q2/2024:-5767000 -5.8M

About Calidi Biotherapeutics Inc & investment objective

Company Information Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 28

Industry Biotechnology

CEO Dr. Eric E. Poma Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Calidi Biotherapeutics Inc FAQs

What is the share price of Calidi Biotherapeutics Inc today?

The current share price of Calidi Biotherapeutics Inc is $0.283.

Can I buy Calidi Biotherapeutics Inc shares in India?

Yes, Indian investors can buy Calidi Biotherapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Calidi Biotherapeutics Inc shares in India?

You can easily invest in Calidi Biotherapeutics Inc shares from India by:

Can I buy fractional shares of Calidi Biotherapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Calidi Biotherapeutics Inc?

Calidi Biotherapeutics Inc has a market cap of $2.69 M.

In which sector does Calidi Biotherapeutics Inc belong?

Calidi Biotherapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Calidi Biotherapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Calidi Biotherapeutics Inc?

The PE ratio of Calidi Biotherapeutics Inc is 0.79 and the PB ratio is 0.41.